These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 32641172)

  • 1. Does remdesivir have any neuropsychiatric adverse effects?
    Gulati G; Kelly BD
    Ir J Psychol Med; 2021 Dec; 38(4):313-314. PubMed ID: 32641172
    [No Abstract]   [Full Text] [Related]  

  • 2. Remdesivir Use in COVID-19 Patients: Cutaneous Adverse Effect or Disease Manifestation?
    Pulsipher KJ; Presley CL; Szeto MD; Waller JD; Dellavalle RP
    J Drugs Dermatol; 2021 May; 20(5):575. PubMed ID: 33938699
    [No Abstract]   [Full Text] [Related]  

  • 3. [Remdesivir for patients with severe COVID-19].
    Augustin M; Hallek M; Nitschmann S
    Internist (Berl); 2020 Jun; 61(6):644-645. PubMed ID: 32333086
    [No Abstract]   [Full Text] [Related]  

  • 4. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?
    Thalha AMM; Lee YY; Besari A; Omar SFS
    J R Coll Physicians Edinb; 2020 Jun; 50(2):159-161. PubMed ID: 32568289
    [No Abstract]   [Full Text] [Related]  

  • 5. Weinreb Amide Approach to the Practical Synthesis of a Key Remdesivir Intermediate.
    Xie Y; Hu T; Zhang Y; Wei D; Zheng W; Zhu F; Tian G; Aisa HA; Shen J
    J Org Chem; 2021 Apr; 86(7):5065-5072. PubMed ID: 33733767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remdesivir: An Antiviral Still Seeking a Raison d'Être.
    Cummins NW
    Clin Infect Dis; 2021 Nov; 73(10):1857-1859. PubMed ID: 33749746
    [No Abstract]   [Full Text] [Related]  

  • 7. The Goldilocks Time for Remdesivir - Is Any Indication Just Right?
    Heil EL; Kottilil S
    N Engl J Med; 2022 Jan; 386(4):385-387. PubMed ID: 34936760
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessing the evidence on remdesivir.
    Núñez I; Soto-Mota A
    Lancet Infect Dis; 2021 Dec; 21(12):1630. PubMed ID: 34838223
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of remdesivir for pregnant patients with severe novel coronavirus disease 2019.
    Igbinosa I; Miller S; Bianco K; Nelson J; Kappagoda S; Blackburn BG; Grant P; Subramanian A; Lyell DJ; El-Sayed YY; Aziz N
    Am J Obstet Gynecol; 2020 Nov; 223(5):768-770. PubMed ID: 32771381
    [No Abstract]   [Full Text] [Related]  

  • 10. Remdesivir: Preliminary Data and Clinical Use Versus Recommended Use.
    Boutzoukas AE; Benjamin DK; Zimmerman KO
    Pediatrics; 2021 May; 147(5):. PubMed ID: 33883244
    [No Abstract]   [Full Text] [Related]  

  • 11. Remdesivir and Potential Interactions With Psychotropic Medications: A COVID-19 Perspective.
    Mansuri Z; Shah B; Zafar MK; Jolly T; Jain S
    Prim Care Companion CNS Disord; 2020 May; 22(3):. PubMed ID: 32470232
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuropsychological adverse drug reactions of Remdesivir: analysis using VigiBase, the WHO global database of individual case safety reports.
    Lee S; Yang JW; Jung SY; Kim MS; Yon DK; Lee SW; Kang HC; Dragioti E; Tizaoui K; Jacob L; Koyanagi A; Salem JE; Kostev K; Lascu A; Shin JI; Kim JH; Smith L
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7390-7397. PubMed ID: 34919240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Halting coronavirus polymerase.
    Kirchdoerfer RN
    J Biol Chem; 2020 Apr; 295(15):4780-4781. PubMed ID: 32277065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral treatment for COVID-19: the evidence supporting remdesivir.
    Richardson C; Bhagani S; Pollara G
    Clin Med (Lond); 2020 Nov; 20(6):e215-e217. PubMed ID: 32863273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncertainty about the Efficacy of Remdesivir on COVID-19.
    Yoo JH
    J Korean Med Sci; 2020 Jun; 35(23):e221. PubMed ID: 32537956
    [No Abstract]   [Full Text] [Related]  

  • 16. Allocating Remdesivir Under Scarcity: Social Justice or More Systemic Racism.
    Weber E; Bliton MJ
    Am J Bioeth; 2020 Sep; 20(9):31-33. PubMed ID: 32840451
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuropsychiatric Manifestations of COVID-19: A Review.
    Foroughi M; Gupta R; Ganguly A; Mirza J; Fotros A
    Adv Psychiatry Behav Health; 2021 Sep; 1(1):161-172. PubMed ID: 38620912
    [No Abstract]   [Full Text] [Related]  

  • 18. Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system.
    Punekar M; Kshirsagar M; Tellapragada C; Patil K
    Microb Pathog; 2022 Jul; 168():105608. PubMed ID: 35654381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute-Onset Psychosis Following Prolonged Hospitalization for COVID-19 Pneumonia.
    Zhang JF; Yoon J; Gokhale V
    Am J Case Rep; 2022 Mar; 23():e936028. PubMed ID: 35351846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatric Adverse Drug Reactions and Potential Anti-COVID-19 Drug Interactions with Psychotropic Medications.
    Ghasemiyeh P; Mortazavi N; Karimzadeh I; Vazin A; Mahmoudi L; Moghimi-Sarani E; MohammadSadeghi A; Shahisavandi M; Kheradmand A; Mohammadi-Samani S
    Iran J Pharm Res; 2021; 20(3):66-77. PubMed ID: 34903970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.